Biomarker Discovery for Precision Medicine: an Artificial Intelligence based approach.
Description of the granted funding
Biomarker development is essential in modern health care, especially in individualization of treatments and precision medicine. Omics has attracted much attention to support discovery of novel biomarkers. However, of the estimated 1M biomarkers identified in omics studies only a small fraction (<1%) has achieved FDA approval. Failures in marker development equate to lost resources, time, and credibility for the field. I aim to use Artificial Intelligence methods to efficiently mine big biomedical data and quickly assess combinations of biomarkers from large-scale omics and clinical data. These AI-driven technologies will be used to discover highly predictive biomarkers of cardiovascular disease (CVD) and Alzheimer disease (AD). By speeding up the translation of omics-driven biomarker models for clinical utility, the proposed study will bring us closer to the future of non-invasive and highly accurate medical tests, which will be accessible and affordable to everyone.
Show moreStarting year
2020
End year
2025
Granted funding
Related funding decisions
358037
Research costs of Academy Research Fellows(2023)
147 220 €
336275
Research costs of Academy Research Fellows(2020)
219 658 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
332510
Fields of science
Biomedicine
Research fields
Systeemibiologia, bioinformatiikka
Identified topics
bioinformatics